Successful treatment of <em>Staphylococcus haemolyticus</em> endocarditis in extremely premature baby with daptomycin
PDF

Keywords

endocarditis
daptomycin
neonate
premature
Staphylococcus haemolyticus
sepsis

How to Cite

Asfour, S. S., Aljobair, F., Hammami, I., Abdelrahim, A., & Al-Mouqdad, M. M. (2018). Successful treatment of <em>Staphylococcus haemolyticus</em> endocarditis in extremely premature baby with daptomycin. Journal of Pediatric and Neonatal Individualized Medicine (JPNIM), 8(1), e080109. https://doi.org/10.7363/080109

Abstract

Daptomycin is a novel lipopeptide antibiotic with rapid activity against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus, coagulase-negative Staphylococci, and Enterococci. We are reporting the first case of successfully using daptomycin to treat infective endocarditis in an extremely premature baby.
https://doi.org/10.7363/080109
PDF